Walvax Biotechnology Co., Ltd.
Underestimation
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| P/E |
3/10
|
48.3 | 69.4 | -30.4% | 158.12 | -69.45% |
| P/S |
|
7.91 | 6.51 | 21.56% |
|
|
| P/BV |
|
4.51 | 3.96 | 14% |
|
|
| P/FCF |
|
0 | 0 | 0% |
|
|
| Ev/Ebitda |
|
31.91 | 11.85 | 169.32% |
|
|
| Ev/S |
|
7.3 | 5.98 | 22.14% |
|
|
| Ev/FCF |
|
0 | 0 | 0% |
|
|
| E/P |
|
0.0207 | 0.0396 | -47.72% |
|
|
Efficiency
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Ebitda margin |
7/10
|
22.13 | 16.34 | 35.43% | 56.9 | -61.11% |
| ROE |
|
9.93 | 11.95 | -16.87% |
|
|
| ROA |
|
4.95 | 5.4 | -8.36% |
|
|
| ROIC |
|
0 | 0 | 0% |
|
|
| ROS |
|
16.39 | 16.23 | 0.9709% |
|
|
| ROCE |
|
0 | 0 | 0% |
|
|
Debt
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Debt/Ebitda |
10/10
|
0.3458 | 14.63 | -97.64% | -0.0386 | -996.98% |
| Nеt Debt/Ebitda |
|
0 | 0 | 0% |
|
|
| Debt/Ratio |
|
0 | 0 | 0% |
|
|
| Debt/Equity |
|
0 | 0 | 0% |
|
|
| Debt/Net Income |
|
0.5777 | 3.6 | -83.95% |
|
|
Dividends
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Dividend yield |
0.1/10
|
0.04 | 1.83 | -97.82% | 0.067 | -40.33% |
| Number of years of dividend growth |
|
0 | 1.44 | -100% | ||
| DSI |
|
0.7857 | 0.9113 | -13.78% |
|
|
| Average dividend growth |
|
-3.39 | 10.4 | -132.64% |
|
|
| Average percentage for 5 years |
|
0.067 | 1.14 | -94.13% |
|
|
| Average percentage for payments |
|
47.19 | 44.8 | 5.34% |
|
|
| Difference from average difference in sector |
|
-1.79 |
Growth impulse
| Parameter | Grade | Value | Sector average | Difference with sector, % | ||
|---|---|---|---|---|---|---|
| Growth impulse Revenue in 5 years |
10/10
|
266.9 | 61.43 | 334.48% | ||
| Growth impulse Ebitda in 5 years |
|
0.2612 | 158.62 | -99.84% | ||
| Growth impulse Net Income in 5 years |
|
195.4 | 66.93 | 191.95% | ||
| Growth impulse FCF in 5 years |
|
-164.96 | 248.41 | -166.41% | ||
| Growth impulse EPS in 5 years |
|
87.76 | 73.29 | 19.74% |
IP Score
5.4/10
